Follow up to five stocks for free. S, a healthcare company, engages in the discovery, development, manufacture, and marketing forex economic calendar indicators of diabetes pharmaceutical products worldwide.

It operates in two segments, Diabetes Care and Obesity, and Biopharmaceuticals. S declared a special dividend on Monday, February 5th. S is scheduled to release their next quarterly earnings announcement on Thursday, August, 9th 2018. S saw a increase in short interest during the month of April. As of April 30th, there was short interest totalling 2,147,542 shares, an increase of 53. S’s management team includes the folowing people: Mr.

S been receiving favorable news coverage? Media headlines about NVO stock have trended somewhat positive on Friday, Accern reports. S’s stock is owned by a number of of retail and institutional investors. NVO stock was sold by a variety of institutional investors in the last quarter, including Folketrygdfondet, Envestnet Asset Management Inc. L P, Fisher Asset Management LLC, Carillon Tower Advisers Inc. Shares of NVO can be purchased through any online brokerage account.

Popular online brokerages with access to the U. 96 billion in revenue each year. S’s mailing address is Novo Alle, Bagsvaerd G7, 2880. P 500 over the long term.

You may vote once every thirty days. S in the last 12 months. There are currently 2 hold ratings and 3 buy ratings for the stock, resulting in a consensus rating of “Buy. 91 per share, with a dividend yield of 2.